When Henry Ford Health System and Michigan State University formally announced a 30-year partnership one year ago today, the organizations set themselves on a trajectory toward a bold vision – to discover and advance a new standard of health to transform life.
It is with that vision in mind that the two organizations mark their first anniversary by expressing gratitude to their respective teams. In a joint letter, Henry Ford Health System President and CEO Wright Lassiter, III, and MSU President Samuel L. Stanley Jr., M.D. said, “There is no question that the challenges of 2021 continued to test all of us in unique ways. In some respect, these challenges have only strengthened our resolve to better the health of our communities by advancing patient care, education, research and innovation on behalf of all people we serve.”
Michigan State University has been awarded a National Institutes of Health $6.7 million grant to build a new facility to develop new imaging agents and treatments for diseases, including cancer, that afflict both humans and large animals.
"The new Large Animal Facility for Imaging and Image-guided Therapies will be one of the few such medical diagnostic facilities in the world," said project leader Anna Moore, assistant dean for the MSU College of Human Medicine and director of the Precision Health Program, adding: “This bridges our existing outstanding basic science and small animal imaging infrastructure, and our human imaging capabilities.”
It’s strange to think that there are nuclear reactions that physicists classify as gentle. After all, the particle accelerators that let scientists study these reactions are nicknamed “atom smashers,” not “atom coddlers.”
But gentle nuclear reactions represent more than a strange-sounding curiosity. These reactions let researchers stress-test certain scientific models that account for how the universe’s fundamental rules work, said Kaitlin Cook of the Facility for Rare Isotope Beams, or FRIB, at Michigan State University.
At Michigan State University, researchers are unlocking the power of genuine collaboration to drive discovery and create healthier tomorrows for all.
Spartan engineers are partnering with biological and health scientists to develop innovative solutions to fight diseases and improve treatments.
“Engineers and biological scientists look at problems differently,” says Christina Chan, University Distinguished Professor, George W. Bissell Professor and interim chairperson of the Department of Chemical Engineering and Materials Science. “The advantage of having different perspectives is that then people come with different backgrounds, and that tends to engender a more creative approach to solving some of these research problems and questions that are raised.”